Why the EpiPen and other off-patents are so expensive – PRI


PRI

Why the EpiPen and other off-patents are so expensive
PRI
The drug, 62 years old at the time, was not covered by a patent and was a key antibiotic used in treating persons with HIV/AIDS. The price hike put patients' health at risk, leading to a cost of hundreds of thousands of dollars for some. Shrekli ...
Vilified for drug pricing, CEO Shkreli busted for securities fraudReuters
$2.6 Billion to Develop a Drug? New Estimate Makes Questionable AssumptionsNew York Times
FDA still struggling with backlog of generic drug applications - Reporting from the frontiers of health and medicineReporting from the frontiers of health and medicine
The New York Times
all 14 news articles »

PRI
Why the EpiPen and other off-patents are so expensive
PRI
The drug, 62 years old at the time, was not covered by a patent and was a key antibiotic used in treating persons with HIV/AIDS. The price hike put patients' health at risk, leading to a cost of hundreds of thousands of dollars for some. Shrekli ...
Vilified for drug pricing, CEO Shkreli busted for securities fraudReuters
$2.6 Billion to Develop a Drug? New Estimate Makes Questionable AssumptionsNew York Times
FDA still struggling with backlog of generic drug applications - Reporting from the frontiers of health and medicineReporting from the frontiers of health and medicine
The New York Times
all 14 news articles »

Leave a Reply

Your email address will not be published. Required fields are marked *